Global Endoscope Market is Set to Reach USD 32.8 billion by 2024, Observing a CAGR of 7.5% during 2019–2024: VynZ Research

    NEXT STORY
    Ascendis Pharma Expands TransCon™ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARA® in the United States
    PREV STORY
    American BriVision Announces Issuance of a Full Clinical Study Report (CSR) for ABV-1504 for Major Depressive Disorder Phase II Study
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Albireo to Host KOL Meeting on Rare Pediatric Liver Diseases on April 12

    BOSTON, April 10, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan ...

    author_avatar
    NASDAQ Market News

    Relievant Medsystems Announces First Patient Enrollment in the INTRACEPT Clinical Study

    SUNNYVALE, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical ...

    author_avatar
    NASDAQ Market News

    Altimmune Restructures Financing Agreement

    GAITHERSBURG, Md., June 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics ...

    author_avatar
    NASDAQ Market News